MannKind Corporation Common Stock (MNKD)

Fast Grower

FairStock Score: 29/100 — RISKY

Key Financials

Current Price$3.09
Market Cap$831M
P/E Ratio-44.14
ROE—%
Dividend Yield—%
SectorHealthcare

Strengths

Concerns

AI Analysis

MannKind Corporation Common Stock is a micro-cap healthcare company valued at $831 million. Revenue stands at $361 million, though the company is currently unprofitable. From a quality standpoint, MannKind shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and distressed Altman Z-Score of -4.8 warrants caution. On valuation, the stock is commanding a steep 178.0x multiple. Growth dynamics show revenue growing at 45.8% and profit growth of -314.9%. Our composite FairStock Score of 29/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

MannKind's 46% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $47 million in annual free cash flow (5.7% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

At 178x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer